These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Free radicals and the treatment of psoriasis with special reference to dithranol. Mustakallio KK; Martinmaa J; Vilvala R; Halmekoski J Med Biol; 1984; 62(2):155-8. PubMed ID: 6471937 [No Abstract] [Full Text] [Related]
63. Woronoff ring during anthralin therapy for psoriasis. Gupta AK; Ellis CN; Goldfarb MT; Voorhees JJ Arch Dermatol; 1986 Mar; 122(3):248. PubMed ID: 3954390 [No Abstract] [Full Text] [Related]
64. Measurement of the response of psoriasis to short-term application of anthralin. Marsden JR; Coburn PR; Marks J; Shuster S Br J Dermatol; 1983 Aug; 109(2):209-18. PubMed ID: 6871098 [TBL] [Abstract][Full Text] [Related]
65. Epidermal nicotinamide adenine dinucleotides in psoriasis during treatment with dithranol. Hammar H Arch Dermatol Forsch; 1975; 252(3):229-36. PubMed ID: 239644 [TBL] [Abstract][Full Text] [Related]
66. Treatment of psoriasis with dithranol cream in general practice. Ellis JP; Hindson TC; Hudson PM; Rhodes EL; Vollum DI; Walker AE Practitioner; 1984 Feb; 228(1388):219-26. PubMed ID: 6701151 [No Abstract] [Full Text] [Related]
67. [A new dithranol cream compared to placebo and ultraviolet therapy in the treatment of psoriasis]. Larkö O Lakartidningen; 1983 Apr; 80(17):1788-90. PubMed ID: 6345972 [No Abstract] [Full Text] [Related]
70. The potential of the essential fatty acid-deficient hairless rat as a psoriasis screening model for topical anti-proliferative drugs. Jensen M; Groth L; Hølmer G; Hansen HS; Fullerton A Skin Pharmacol Appl Skin Physiol; 2002; 15(6):401-13. PubMed ID: 12476014 [TBL] [Abstract][Full Text] [Related]
71. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. Leigh IM; Navsaria H; Purkis PE; McKay IA; Bowden PE; Riddle PN Br J Dermatol; 1995 Oct; 133(4):501-11. PubMed ID: 7577575 [TBL] [Abstract][Full Text] [Related]
72. [A new method of local treatment of psoriasis]. Brody I Lakartidningen; 1979 Feb; 76(9):730-2. PubMed ID: 763042 [No Abstract] [Full Text] [Related]
73. [Treatment of psoriasis using Cignolin (dihydroxyanthranol): CSP (Cignolin-Salicylic acid-Petrolatum) - treatment schedule from Cologne]. Orfanos CE; Steigleder GK Z Hautkr; 1976 Jun; 51(12):473-80. PubMed ID: 952029 [No Abstract] [Full Text] [Related]
74. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone). Mustakallio KK; Brandt H Acta Derm Venereol; 1984; 64(1):63-6. PubMed ID: 6203285 [TBL] [Abstract][Full Text] [Related]
75. Should general practitioners use dithranol? Donaldson J; Cunliffe WJ Br Med J (Clin Res Ed); 1983 Jun; 286(6382):1939-40. PubMed ID: 6407648 [No Abstract] [Full Text] [Related]
76. [Our experience with Ingram's treatment of psoriasis modified by Farbes and Harris]. Vilata JJ; de la Cuadra J; Aliaga A; Marquina A Actas Dermosifiliogr; 1974; 65(5-6):254-8. PubMed ID: 4467697 [No Abstract] [Full Text] [Related]
79. [Distribution of dithranol therapy in dermatologic clinics and specialty practice in Switzerland]. Pflugshaupt C Schweiz Rundsch Med Prax; 1985 Feb; 74(7):159-61. PubMed ID: 3975529 [No Abstract] [Full Text] [Related]
80. Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis. Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD J Exp Med; 1993 Oct; 178(4):1271-81. PubMed ID: 7690831 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]